Figure 1From: A phase II study on safety and efficacy of high-dose N-acetylcysteine in patients with cystic fibrosis A. A CONSORT study flow chart of patient enrolment, follow-up and analysis. B. Study design. Visit 3 (at the end of placebo run-in phase) was defined as baseline for subsequent analyses.Back to article page